Top Markets
Coin of the day
Vasamed, Inc. Vasamed, Inc.

Vasamed, Inc.

VSMD
Rank in Stocks #42568
Vasamed, Inc. specializes in the development, manufacturing, licensing, and... Vasamed, Inc. specializes in the development, manufacturing, licensing, and distribution of a comprehensive suite of products, software solutions, and services focused on the assessment and management of circulatory health throughout the United States. Key among its offerings is the SensiLase PAD-IQ, a device designed to measure skin perfusion pressure, conduct pulse volume recordings, and calculate the Ankle-Brachial Index utilizing Doppler-derived pressure readings. The company also provides advanced Wound Imaging & SmartDraw systems for precise wound measurement. Additionally, Vasamed offers the PAD-IQ Studycast, a platform that facilitates the rapid and secure transmission of diagnostic test results to vascular specialists. This enables prompt interpretation of findings and supports timely, medically indicated therapeutic interventions. For safeguarding its equipment, the company also supplies a custom carrying case for the PAD-IQ system. Vasamed caters to both clinicians and patients, and has been operating since its founding in 1988. Its corporate headquarters are located in Eden Prairie, Minnesota.
Share Price
$0.0001
Last synced: 2026-08-11
Market Cap
$802.00
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Vasamed, Inc. (VSMD)

Category

P/S ratio for Vasamed, Inc. (VSMD)
P/S ratio as of 2026 TTM: 0
According to Vasamed, Inc. latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for Vasamed, Inc. from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
11.31 -
US
2.57 -
FR
- -
JP
2.81 -
US
- -
CH